Navigation Links
One Sigmoidoscopy Boosts Colon Cancer Survival Odds
Date:4/27/2010

Single exam between ages 55 and 64 confers lasting benefit, researchers say

TUESDAY, April 27 (HealthDay News) -- Adults who undergo a sigmoidoscopy examination between ages 55 and 64 could significantly reduce their odds of developing and dying from colorectal cancer, new research shows.

Flexible sigmoidoscopy enables doctors to look for cancers and symptomless growths called adenomas in the rectum and sigmoid (lower) colon, where two-thirds of colorectal cancers occur. Sigmoidoscopy does not examine the upper colon, as colonoscopy does.

Noting that most people with distal colon cancer (rectum and lower colon) will have developed an adenoma by age 60, the researchers theorized that removing adenomas through sigmoidoscopy would provide lasting protection.

In a long-term study, British researchers found that having the cancer-screening test just once in that age range reduced the incidence of colorectal cancer by one-third.

"The results from our trial show that flexible sigmoidoscopy is a safe and practical test and, when offered only once to people between ages 55 and 64 years, confers a substantial and long-lasting protection from colorectal cancer," the authors wrote in a study released online April 27 in advance of publication in an upcoming print issue of The Lancet.

Colorectal cancer is the third most common cancer worldwide (fourth in the United States), resulting in one million diagnoses and 600,000 deaths a year. Survival rates are good for cancers that haven't spread, so early detection is key.

Many countries promote fecal occult blood tests for early screening, but that technique reduces mortality by only 15 percent, according to background information in the study.

For their study, begun nearly 16 years ago and conducted in England, Wales and Scotland, the research team followed almost 113,000 men and women in a control group and another 57,099 participants in an intervention group, of which 40,674 (71 percent) underwent flexible sigmoidoscopy.

Over an average 11 years of follow-up, 2,524 participants were diagnosed with colorectal cancer (1,818 in the control group and 706 in the intervention group). Deaths certified from colorectal cancer totaled 727 (538 in the control group, and 189 in the intervention group), the study authors noted.

Incidence of distal colorectal cancer fell by 50 percent. Cases of colorectal cancer among those screened were reduced by 33 percent and deaths by 43 percent, the authors said.

"Confining results to the rectum and sigmoid (lower) colon, incidence was reduced by half in those who were screened," wrote Wendy Atkin of Imperial College London, and colleagues.

More information

To learn more about flexible sigmoidoscopy, see the U.S. National Institute of Diabetes and Digestive and Kidney Diseases.



-- Margaret Steele



SOURCE: The Lancet, news release, April 27, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Biking to School Boosts Kids Fitness
2. Using Nicotine Patch Longer Boosts Efforts to Quit
3. Original Sewing & Quilt Expo Boosts Benefits
4. New study shows TGen spin-off boosts Scottsdale economy
5. Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices Across Europe, Finds Frost & Sullivan
6. Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via
7. Procedure Boosts Outcomes in Implantable Defibrillator Patients
8. A midday nap markedly boosts the brains learning capacity
9. Dry Weather Boosts Odds of Flu Outbreaks
10. Fitness Boosts Brain Power in Multiple Sclerosis Patients
11. Ritalin Boosts Learning by Increasing Brain Plasticity, According to UCSF Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology: